ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO1103

Timely Creation of Peripheral Vascular Access for Planned Initiation of Hemodialysis

Session Information

  • Vascular Access - II
    November 09, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Dialysis

  • 704 Dialysis: Vascular Access

Authors

  • Chiu, Yi-Wen, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Lim, Lee-Moay, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
  • Lin, Ming-Yen, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Hwang, Shang-Jyh, Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
Background

Factor associated with timely creation of peripheral vascular access (VA) for planned initiation of hemodialysis is not clear.

Methods

From 2003 through 2016, every patient enrolled in integrated CKD program for more than 6 months and closed with the status of HD were included. The eGFR slope was counted between CKD program enrollment and VA creation or starting HD, which came first. We defined VA created timely as using VA when starting HD.

Results

Total 998 ESKD patients were included. (Age 65±12 y/o, Male 53%, DM 50%) The portion of VA created timely, created not timely and not created were 69%, 9% and 22%, respectively. By calendar year, created timely had the percentage increasing and around 74% in the last 6 years. Compared with not created, VA created timely had shallower eGFR slope (-4.2(-7.4, -2.3) vs -5.6(-10.8, -3.1), ml/min/1.73m2/yr; p<0.0001), lower eGFR on first HD (4.3(3.4, 5.4) vs 4.6(3.4, 6.0), ml/min/1.73m2; p=0.011) and longer stay at CKD program (729(417, 1439) vs 504(309, 1077), days; p<0.0001). There was a negative association of eGFR at VA creation with eGFR slope among VA created before HD (figure 1, r=-0.182, p<0.0001). Compared with created not timely, VA created timely had longer duration after VA creation till HD (108(53, 237) vs 14(7, 28); p<0.0001), shallower eGFR slope (-4.2(-7.4, -2.3) vs -4.8(-9.7, -2.2); p<0.0001), higher eGFR at VA creation (5.9(4.8, 7.2) vs 5.1(3.8, 7.1); p<0.005) and longer stay at CKD program (729(417, 1439) vs 521(312, 1048); p<0.0001). In multivariable analysis, only higher eGFR at VA creation (p=0.004) and shallower eGFR slope (p=0.05) were significant with timely creation of VA.

Conclusion

We disclosure that the stay in CKD program and eGFR slope are associated with timely creation of peripheral VA for HD initiation, and may be helpful with determining the time of peripheral VA creation.